Ultromics is a global health technology company which provides autonomous echocardiography analysis through innovative AI solutions – empowering physicians to make fast, accurate decisions when diagnosing cardiovascular disease.
Our cloud-based service, EchoGo, uses artificial intelligence to fully automate the pathway to diagnosis, providing near-instant reports for clinicians without any need for physical software on site. Our aim is to save clinicians time and allow them to confidently make diagnostic decisions. We are helping healthcare providers streamline care, increase productivity and improve patient outcomes whilst also allowing them to make valuable resource and cost savings.
For more information about Ultromics visit http://www.ultromics.com/
Location: United Kingdom, England, Oxford
Employees: 51-200
Total raised: $56.44M
Founded date: 2017
Investors 6
| Date | Name | Website |
| 08.09.2021 | Optum Vent... | optumventu... |
| - | Oxford Uni... | innovation... |
| - | NovaCapita... | novacapita... |
| - | Oxford Sci... | oxfordscie... |
| 22.10.2021 | GV | gv.com |
| 16.11.2021 | Blue Ventu... | blueventur... |
Funding Rounds 3
| Date | Series | Amount | Investors |
| 16.08.2021 | Series B | $33M | - |
| 17.06.2020 | - | $10M | - |
| 22.05.2018 | Series A | $13.44M | - |
Mentions in press and media 18
| Date | Title | Description | Source |
| 11.01.2024 | Ultromics Expedites Echo AI for Early Cardiac Amyloidosis De... | Under the partnership with Pfizer, Ultromics will research and pursue FDA clearance for its EchoGo A... | aithority.... |
| 15.03.2023 | Slone Partners Places John Russell as Executive Chairman at ... | “John Russell is a highly-respected MedTech engineer, executive, and Board Member with a stellar tra... | prweb.com/... |
| 01.03.2023 | Ultromics Announces New Chairman of The Board | John Russell, Executive Chairman, Ultromics. Ultromics announces the appointment of John Russell as ... | einpresswi... |
| 10.10.2022 | AI outperforms human analysis in predicting cardiac outcomes... | Clinician viewing AI-derived report sent by Ultromics. Ultromics logo Ultromics’ AI technology analy... | einpresswi... |
| 16.12.2021 | Artificial Intelligence Improves Coronary Artery Disease Det... | A new study published, Automated Echocardiographic Detection of Severe Coronary Artery Disease Using... | aithority.... |
| 09.11.2021 | Ultrasound AI companies Caption Health and Ultromics partner... | This comes after Caption partnered with Butterfly Network's handheld ultrasound devices in August Ul... | vator.tv/n... |
| 18.08.2021 | Ultromics raises $33M to build out its AI-enabled cardiovasc... | Heart disease is responsible for one death every eight minutes in the United Kingdom Cardiovascular ... | vator.tv/n... |
| 17.08.2021 | Ultromics Raises $33M in Series B Funding | Ultromics, an Oxford, UK-based company focused on advancing AI enabled cardiovascular imaging soluti... | finsmes.co... |
| 16.08.2021 | Ultromics racks up $33M to drive its cardiac ultrasound AI s... | After netting an FDA clearance at the top of this year for its artificial intelligence-powered ultra... | fiercebiot... |
| 16.08.2021 | Ultromics Raises $33M for AI-Enabled Echocardiograms to Help... | What You Should Know: – Today, Ultromics, an Oxford, England-based health-tech startup announced it ... | hitconsult... |
Show more